Portfolio Companies 2026 for Astellas Venture Management: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Astellas Venture Management accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.5B. The median disclosed raise is $72M, and the largest is Effector Therapeutics at $325M, ahead of Viamet Pharmaceuticals ($178M) and Casma Therapeutics ($162M).
The names that recur most often on these portfolio cap tables are Astellas Venture Management (13 companies), Novartis Venture Fund (3 companies), MPM Capital (3 companies), DCVC Bio (2 companies), Longwood Fund (2 companies), Alexandria Venture Investments (2 companies). By latest disclosed round, the market skews Series A (7), Series B (3), Series D (1), Grant (1).
Astellas Venture Management alternatives · All research reports